Stock Market Closing Bell: Sensex crashes 1,048 pts, Nifty slides 1.30% as tech rout drags markets

HUL-Kwality Walls Demerger Big Update: FMCG Major’s ice cream unit shares to list on NSE, BSE - Check date

CPI new method market additions skewed towards few states; UP and Maharashtra corner 43% of new markets, says SBI report

Info Edge Q3 FY26 Results: Naukri.com parent net profit rises 12%; Declares 120% dividend - Check record date 

IEX shares fall 4% as APTEL dismisses plea, allows CERC to proceed with market coupling

Gold ETF or Silver ETF? Which precious metal exchange-traded funds are worth investing in now - Expert answers

Stock Market Crash: Sensex sinks 800 pts, Mid & Smallcaps bleed; only 1 stock in green

RSS centenary film 'Shatak' to hit theatres on February 19

Defence stocks to buy: Rs 3.60 lakh crore push lifts outlook - HAL, Bharat Forge seen with up to 40% upside

Bears Dominate Dalal Street! Sensex opens 772 points lower, Nifty dips below 25,600 – IT, metals, FMCG lead losses

Sun Pharma share price is expected to deliver around 11 per cent returns if a stock market investor decides to buy the stock at its current levels of around Rs 400 per share. Stock market experts are of the opinion that Sun Pharma stocks' 21 days exponential moving average indicates an upside momentum while its RSI positive divergence is also promising for the traders. Experts are of the opinion that the counter may show Rs 445 per stock levels in short-term perspective means in around one-month period. 
Speaking on the short-term technical outlook of the Sun Pharma share price Gajendra Prabu, Technical Research Analyst, HDFC Securities said, "The stock has validated the Hammer candle pattern formed on the weekly chart (moved above candle’s high) which is confirmation of the bullish reversal. Price has provided a breakout of key short term trendline. Price has started to form a higher top and higher bottom on intraday charts which is a bullish development. In addition, technical indicators are placed in favour of bulls; this could add strength to bulls." 
See Zee Business video below:
<blockquote data-lang="en">देखिए <a href="https://twitter.com/hashtag/Twitter?src=hash&amp;ref_src=twsrc%5Etfw">#Twitter</a> पर 1,00,000<a href="https://twitter.com/hashtag/Follower?src=hash&amp;ref_src=twsrc%5Etfw">#Follower</a> पूरे होने पर क्या कहा अनिल सिंघवी ने..<a href="https://twitter.com/AnilSinghviZEE?ref_src=twsrc%5Etfw">@AnilSinghviZEE</a> <a href="https://t.co/LCJec9XO76">pic.twitter.com/LCJec9XO76</a>
— Zee Business (@ZeeBusiness) <a href="https://twitter.com/ZeeBusiness/status/1144179708575154176?ref_src=twsrc%5Etfw">June 27, 2019</a></blockquote>
<script async="" src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>On the suggestion to the stock market investors, Gajendra Prabu of HDFC securities said, "Traders may look to buy the stock at CMP and add on dips to Rs 385 for the upside target of Rs 445 over the next 2-3 weeks. Place a stop loss at Rs 377."
Giving details of the fundamentals of Sun Pharma counter Prakash Pandey, Head of Research at Fairwealth Securities said, "Exponential moving average of the Sun Pharma shares is indicating an upside momentum while its RSI Positive Divergence is also supporting the bull run in the pharma counter. I would suggest stock market investors take a buy position in the counter for around 10-12 per cent gains in short-term means around one-month time period."

Sun Pharma share price is expected to deliver around 11 per cent returns if a stock market investor decides to buy the stock at its current levels of around Rs 400 per share. Stock market experts are of the opinion that Sun Pharma stocks' 21 days exponential moving average indicates an upside momentum while its RSI positive divergence is also promising for the traders. Experts are of the opinion that the counter may show Rs 445 per stock levels in short-term perspective means in around one-month period. Speaking on the short-term technical outlook of the Sun Pharma share price Gajendra Prabu, Technical Research Analyst, HDFC Securities said, "The stock has validated the Hammer candle pattern formed on the weekly chart (moved above candle’s high) which is confirmation of the bullish reversal. Price has provided a breakout of key short term trendline. Price has started to form a higher top and higher bottom on intraday charts which is a bullish development. In addition, technical indicators are placed in favour of bulls; this could add strength to bulls." See Zee Business video below:देखिए #Twitter पर 1,00,000#Follower पूरे होने पर क्या कहा अनिल सिंघवी ने..@AnilSinghviZEE pic.twitter.com/LCJec9XO76— Zee Business (@ZeeBusiness) June 27, 2019On the suggestion to the stock market investors, Gajendra Prabu of HDFC securities said, "Traders may look to buy the stock at CMP and add on dips to Rs 385 for the upside target of Rs 445 over the next 2-3 weeks. Place a stop loss at Rs 377."Giving details of the fundamentals of Sun Pharma counter Prakash Pandey, Head of Research at Fairwealth Securities said, "Exponential moving average of the Sun Pharma shares is indicating an upside momentum while its RSI Positive Divergence is also supporting the bull run in the pharma counter. I would suggest stock market investors take a buy position in the counter for around 10-12 per cent gains in short-term means around one-month time period."

Sun Pharma stock has validated the Hammer candle pattern formed on the weekly chart (moved above candle’s high) which is confirmation of the bullish reversal.

Share to buy: Sun Pharma set to give 11 pct returns in one month, say experts

news-share-to-buy-sun-pharma-set-to-give-11-pct-returns-in-one-month-say-experts-103615

Sun Pharma share price is expected to deliver around 11 per cent returns if a stock market investor decides to buy the stock at its current levels of around Rs 400 per share. Stock market experts are of the opinion that Sun Pharma stocks 21 days exponential moving average indicates an upside momentum while its RSI positive divergence is also promising for the traders. Experts are of the opinion that the counter may show Rs 445 per stock levels in short-term perspective means in around one-month period.  Speaking on the short-term technical outlook of the Sun Pharma share price Gajendra Prabu, Technical Research Analyst, HDFC Securities said, The stock has validated the Hammer candle pattern formed on the weekly chart (moved above candle’s high) which is confirmation of the bullish reversal. Price has provided a breakout of key short term trendline. Price has started to form a higher top and higher bottom on intraday charts which is a bullish development. In addition, technical indicators are placed in favour of bulls; this could add strength to bulls.  See Zee Business video below: देखिए #Twitter पर 1,00,000#Follower पूरे होने पर क्या कहा अनिल सिंघवी ने..@AnilSinghviZEE pic.twitter.com/LCJec9XO76 — Zee Business (@ZeeBusiness) June 27, 2019 On the suggestion to the stock market investors, Gajendra Prabu of HDFC securities said, Traders may look to buy the stock at CMP and add on dips to Rs 385 for the upside target of Rs 445 over the next 2-3 weeks. Place a stop loss at Rs 377. Giving details of the fundamentals of Sun Pharma counter Prakash Pandey, Head of Research at Fairwealth Securities said, Exponential moving average of the Sun Pharma shares is indicating an upside momentum while its RSI Positive Divergence is also supporting the bull run in the pharma counter. I would suggest stock market investors take a buy position in the counter for around 10-12 per cent gains in short-term means around one-month time period.